CN106190993A - 禽流感疫苗和诊断抗原所用种毒的制备方法 - Google Patents

禽流感疫苗和诊断抗原所用种毒的制备方法 Download PDF

Info

Publication number
CN106190993A
CN106190993A CN201510502806.5A CN201510502806A CN106190993A CN 106190993 A CN106190993 A CN 106190993A CN 201510502806 A CN201510502806 A CN 201510502806A CN 106190993 A CN106190993 A CN 106190993A
Authority
CN
China
Prior art keywords
avian influenza
virus
vaccine
influenza vaccine
diagnostic antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510502806.5A
Other languages
English (en)
Inventor
蒋文明
陈继明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHINA ANIMAL HEALTH AND EPIDEMIOLOGY CENTER
Original Assignee
CHINA ANIMAL HEALTH AND EPIDEMIOLOGY CENTER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHINA ANIMAL HEALTH AND EPIDEMIOLOGY CENTER filed Critical CHINA ANIMAL HEALTH AND EPIDEMIOLOGY CENTER
Publication of CN106190993A publication Critical patent/CN106190993A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

本发明涉及兽医生物制品领域,用于制备禽流感疫苗和诊断抗原所需种毒。本发明应用反向遗传技术,以流感病毒冷适应株的内部六个基因(PB2、PB1、PA、NP、M、NS)为基因组骨架,与禽流感病毒HA和NA基因一起,人工构建流感病毒,该病毒作为制备禽流感疫苗和诊断抗原所需种毒,具有更高的安全性,并保持效价高、匹配性强等优点,制备的弱毒疫苗或灭活疫苗安全可靠,免疫后能够产生较强免疫力,能够有效预防禽流感的流行和传播,降低本病造成的经济损失,降低对人类健康的威胁,具有重要的公共卫生意义,有着广阔的应用前景。

Description

禽流感疫苗和诊断抗原所用种毒的制备方法
技术领域
本发明涉及禽流感疫苗和诊断抗原所用种毒的制备方法,属于生物技术领域。
背景技术
禽流感(Avian influenza,AI)是由禽流感病毒引起的一种家禽和野禽的传染病。禽流感病毒根据血凝素(HA)和神经氨酸酶(NA)的不同,可分为16个HA亚型和9个NA亚型。高致病性禽流感是由某些H5或H7亚型禽流感病毒引起的严重威胁禽类的烈性传染病。有些高致病性禽流感病毒还能引起人的感染、发病,甚至死亡。
2003年以来,H5N1亚型高致病性禽流感一直在包括中国在内的多个国家和地区流行,不但给养禽业造成了严重的经济损失,还严重威胁着人类的健康。除了不断加强和完善流感监测以外,疫苗仍然是防控AI的重要手段。2005年,我国开始实施针对禽流感的大规模强制性免疫政策,并取得了显著成效。随着病毒的不断变异,疫苗也从Re-1更新到Re-4和Re-5,到目前的Re-6和Re-7。所有这些疫苗都是通过PR8(A/PR/8/34)的六个内部基因和流行毒株的HA和NA两个外部基因重组而成。由于PR8病毒对哺乳动物的高亲和力,出于安全性考虑,所有PR8重组而来的这些疫苗只能制成灭活疫苗使用。灭活疫苗主要通过诱导抗体产生来保护机体免受病毒攻击,病毒在抗体免疫压力下变异速度会加快,使得病毒更难以预防和控制。本专利提供了一种新的禽流感疫苗和诊断抗原所用种毒的制备方法。种毒,作为疫苗生产的“种子”,是疫苗生产的关键所在。配套的诊断抗原是疫苗质量控制和疫苗使用效果评价的必要材料,而种毒是配套的血凝试验或血凝抑制试验诊断抗原生产的必要材料。
发明内容
本专利首次确定利用冷适应株流感病毒A/Ann Arbor/6/60(AAca)的六个内部基因(PB2、PB1、PA、NP、M和NS)和流行毒株的外部基因(HA和NA),通过反向遗传操作技术,禽流感疫苗和诊断抗原所需种毒。反向遗传操作技术是指通过某个或某些人工构建的质粒,转染特定的细胞,产生所希望获得的病毒的一种技术。利用冷适应株流感病毒A/AnnArbor/6/60(AAca)和反向遗传技术制备禽流感疫苗和诊断抗原所需种毒具有更高的安全性,并保持效价高、匹配性强等优点,制备的弱毒疫苗或灭活疫苗安全可靠,免疫后能够产生较强免疫力,能够有效预防禽流感的流行和传播,降低本病造成的经济损失,降低对人类健康的威胁,具有重要的公共卫生意义,有着广阔的应用前景。
本专利首次确定用反向遗传技术制备禽流感疫苗过程中所需病毒骨架的六个内部基因序列。
具体实施方式
下面通过实施例,进一步说明本发明的技术方案,但本发明的保护范围不限于此。
实施例中所述的表达A/Ann Arbor/6/60(AAca)病毒六个内部基因的重组质粒由中国动物卫生与流行病学中心构建保存,293T细胞购自QbioGene公司;脂质体Lipofectamine2000购自Invitrogen公司。
实施例1
重组H5亚型禽流感病毒(rH5/AAca)的构建方法,包括如下步骤:
1、人工合成与克隆A/Ann Arbor/6/60(AAca)六个内部基因
按照本发明指定的PB2、PB1、PA、NP、M、NS基因序列(SEQ ID NO.1~NO.6),采用人工合成的方法,将其***到双向表达载体(能同时转录产生病毒RNA和mRNA)中,制得pH-PB2、pH-PB1、pH-PA、pH-NP、pH-M、pH-NS质粒。
2、H5亚型禽流感病毒表面基因的克隆
扩增H5亚型禽流感病毒HA和NA表面基因,并对HA基因进行分子修饰,去除与H5亚型禽流感病毒致病力有关的HA蛋白裂解位点处的多个碱性氨基酸,使其获得低致病性禽流感病毒的分子特征(即将-PLRERRRKR-突变为-PQRETR-),将其***到双向表达载体中,制得pH-mHA和质粒pH-NA。
3、重组H5亚型禽流感病毒的包装与鉴定
表达A/Ann Arbor/6/60(AAca)病毒的6个内部基因重组表达质粒,与表达H5亚型禽流感病毒HA和NA基因重组质粒,经脂质体Lipofectamine 2000共转染293T细胞。将转染细胞经尿囊腔接种于10日龄SPF鸡胚,每胚0.1mL,每个样品接种两个胚,置35℃培养至72h,收集尿囊液,用国际兽疫局(OIE)推荐的标准进行血凝(HA)和血凝抑制(HI)试验鉴定病毒。HI阳性尿囊液,用鸡胚传代的第2代尿囊液提取RNA、RT-PCR扩增HA和NS基因片段进行测序。未经反转录的RNA用PCR扩增。RT-PCR扩增及测序结果表明,拯救的病毒为重组H5亚型禽流感病毒,未经反转录的RNA用PCR无扩增条带。获得重组病毒命名为rH5/AAca。
4、疫苗生产所需病毒的增殖方法
以无菌生理盐水1∶10000倍稀释rH5/AAca病毒,经尿囊腔接种10日龄SPF鸡胚,0.1mL/胚,收获培养72h后的存活鸡胚尿囊液,测定HA效价,病毒尿囊液HA效价为29,且无菌检验合格。
5、疫苗生产所需的病毒灭活方法
将收获的尿囊液中加入***至终浓度0.2%,2-8℃灭活48h,每隔2h摇匀一次。灭活48h后,每个病毒样品接种10枚鸡胚,每胚0.1mL,孵化72h后测定HA效价,无血凝性的尿囊液再盲传一代。第二代仍无血凝性判为病毒完全灭活。结果病毒尿囊液鸡胚传代2次均无产生血凝性,灭活完全。
6、灭活疫苗的质量检测
按《兽医生物制品规程》的方法制备rH5/AAca株油乳剂灭活疫苗并进行疫苗的无菌试验、物理性状、安全性检测。各项指标符合《兽医生物制品规程》的规定。
7、疫苗的免疫效力试验
将50只21日龄SPF鸡随机分为5组,每组10只。第1-4组肌肉接种质量检测合格的rH5/AAca禽流感疫苗,免疫剂量分别为0.05、0.1、0.3、0.5mL/只,第5组为空白对照组,隔离饲养。免疫后2周和3周,采血测定H5亚型禽流感病毒抗体水平。免疫后3周用同源H5亚型高致病性禽流感病毒攻毒,判定疫苗的免疫保护效果(表1)。
H5亚型禽流感病毒灭活疫苗的不同免疫剂量对免疫效力的影响试验结果表明,所研制的疫苗免疫剂量为0.1mL/只就可使免疫鸡群在免疫后3周就可以获得对H5病毒的保护。从抗体产生水平来看,0.3mL/只免疫剂量组鸡的抗体水平明显高于0.1mL组,且0.3mL组抗体水平保持稳定上升。多重比较表明,0.3与0.5mL组抗体效价变化差异不显著(P>0.05),说明同样条件下选用0.3mL/只剂量接种能达到理想的防疫效果。
表1重组H5亚型禽流感病毒油乳剂灭活疫苗的免疫效力试验
注:*分母表示试验鸡数,分子表示死亡的鸡只数。
8、H5亚型禽流感病毒作为诊断抗原的方法
H5亚型禽流感病毒的增殖方法同步骤4。H5亚型禽流感病毒的增殖方法同步骤4、灭活方法同步骤5。用此灭活病毒进行血凝抑制试验检测相匹配的疫苗免疫效果(HI抗体滴度),如步骤7所示。
SEQUENCE LISTING
<110> 中国动物卫生与流行病学中心
<120> 禽流感疫苗和诊断抗原所用种毒的制备方法
<160> 6
<170> PatentIn version 3.3
<210> 1
<211> 2341
<212> DNA
<213> Influenza virus
<400> 1
agcgaaagca ggtcaattat attcaatatg gaaagaataa aagaactacg gaatctgatg 60
tcgcagtctc gcactcgcga gatactaaca aaaaccacag tggaccatat ggccataatt 120
aagaagtaca catcagggag acaggaaaag aacccgtcac ttaggatgaa atggatgatg 180
gcaatgaaat atccgattac agccgacaag aggataacag aaatgattcc tgagagaaat 240
gagcaagggc aaactctatg gagtaaaatg agtgatgccg gatcggatcg tgtgatggta 300
tcacctctgg ctgtgacatg gtggaataga aatggaccaa tgacaagtac ggttcattat 360
ccaaaaatct acaaaactta ttttgagaaa gtcgaaaggt taaaacatgg aacctttggc 420
cctgttcatt ttagaaacca agtcaaaata cgccgaagag ttgacataaa tcctggtcat 480
gcagacctca gtgccaagga ggcacaggat gtaatcatgg aagttgtttt ccctaacgaa 540
gtgggggcca ggatactaac gtcggaatcg caattaacaa taaccaaaga gaaaaaagaa 600
gaactccagg attgcaaaat ttcacctttg atggttgcgt acatgttaga gagagaactt 660
gtccgaaaaa cgagatttct cccagttgct ggtggaacaa gcagtgtgta catcgaagtg 720
ttgcacttga ctcaaggaac atgctgggaa cagatgtaca ctccaggtgg agaagtgagg 780
aatgatgatg ttgatcaaag tctaattatt gcagccagga gcatagtgag aagagcagca 840
gtatcagcag atccactagc atctttattg gagatgtgcc acagcacaca gattggcggg 900
acaaggatgg tggacattct taggcagaac ccaacagaag agcaagctgt ggaaatatgc 960
aaagctgcaa tgggactgag gatcagctca tccttcagtt ttggcgggtt cacatttaag 1020
agaacaagcg gatcatcagt caagagagag gaagaagtgc ttacgggcaa tcttcaaaca 1080
ttgaaaataa gggtgcatga gggatacgag gagttcacaa tggttgggaa aagggcaaca 1140
gctatactca gaaaagcaac caggagattg attcagctga tagtgagtgg aagagacgaa 1200
cagtcgatag ccgaagcaat aattgtggcc atggtatttt cacaagaaga ttgtatgata 1260
aaagcagtta gaggtgatct gaatttcgtt aatagggcaa atcagcgatt gaatcccatg 1320
catcaacttt taagacattt tcagaaggat gctaaagtgc tttttcaaaa ttggggaatt 1380
gaacatatcg acaatgtgat gggaatgatt ggggtattac cagacatgac tccaagcaca 1440
gagatgtcaa tgagaggggt aagagtcagc aaaatgggcg tagatgaata ctccagcgcg 1500
gagagagtag tggtgagcat tgaccggttt ttgagagttc gagaccaacg aggaaatgta 1560
ctactatctc ctgaggaggt cagtgaaaca cagggaacag agaaactgac aataacttac 1620
tcatcgtcaa tgatgtggga gattaatggc cctgagtcag tgttggtcaa tacctatcag 1680
tggatcatca gaaactggga aactgttaaa attcagtggt ctcagaatcc tacaatgcta 1740
tacaataaaa tggaatttga gccatttcag tctttagttc ctaaggccat tagaggccaa 1800
tacagtgggt ttgttaggac tctattccaa caaatgaggg atgtacttgg gacatttgat 1860
accacccaga taataaaact tcttcccttt gcagccgccc caccaaagca aagtagaatg 1920
caattctctt cattgactgt gaatgtgagg ggatcaggaa tgagaatact tgtaaggggc 1980
aattctccta tattcaacta caacaagacc actaagagac taacaattct cggaaaggat 2040
gctggcactt taactgaaga cccagatgaa ggcacatctg gagtggagtc cgctgttctg 2100
agaggattcc tcattctggg caaagaagat aggagatatg gaccagcatt aagcatcaat 2160
gaactgagta accttgcgaa aggagaaaag gctaatgtac taattgggca aggagacgtg 2220
gtgttggtaa tgaaacgaaa acggaactct agcatactta ctgacagcca gacagcgacc 2280
aaaaggattc ggatggccat caattaatgt tgaatagttt aaaaacgacc ttgtttctac 2340
t 2341
<210> 2
<211> 2341
<212> DNA
<213> Influenza virus
<400> 2
agcgaaagca ggcaaaccat ttgaatggat gtcaatccga ccttactttt cttgaaagtt 60
ccagcgcaaa atgccataag tactacattc ccttatactg gagatcctcc atacagccat 120
ggaacaggaa caggatacac catggacaca gtcaacagaa cacatcaata ttcagaaaag 180
gggaagtgga caacaaacac ggaaactgga gcgcaccaac ttaacccaat tgatggacca 240
ctacctgagg acaatgaacc aagtggatat gcacaaacag actgcgtcct ggaagcaatg 300
gctttccttg aagaatccca cccaggaatc tttgaaaact cgtgtcttga aacgatggaa 360
gttattcaac aaacaagagt ggacaaactg acccaaggtc gtcagaccta tgattggaca 420
ttgaacagaa atcagccggc tgcaactgcg ctagccaaca ctatagaggt cttcagatcg 480
aatggcctga cagctaatga atcgggaagg ctaatagatt tcctcaagga tgtgatagaa 540
tcaatggata aagaggagat ggaaatcaca acacacttcc aaagaaaaag aagagtaaga 600
gacaacatga ccaagaaaat ggtcacacaa cgaacaatag gaaagaagaa gcaaagattg 660
aacaagagaa gctatctaat aagagcactg acattgaaca caatgactaa agatgcagag 720
agaggtaaat taaagagaag agcaattgca acacccggta tgcagatcag agggttcgtg 780
tactttgtcg aaacactagc gagaagtatt tgtgagaagc ttgaacagtc tgggcttccg 840
gttggaggta atgaaaagaa ggctaaactg gcaaatgttg tgcgaaaaat gatgactaat 900
tcacaagaca cagagctctc tttcacaatt actggagaca ataccaaatg gaatgagaat 960
caaaatcctc ggatgttcct ggcgatgata acatacatca caagaaatca acctgaatgg 1020
tttagaaacg tcctgagcat cgcacctata atgttctcaa ataaaatggc aagactaggg 1080
aaaggataca tgttcaaaag caagagcatg aagctccgaa cacaaatacc agcagaaatg 1140
ctagcaagta ttgacctgaa atactttaat gaatcaacaa gaaagaaaat cgaggaaata 1200
aggcctctcc taatagatgg cacagtctca ttgagtcctg gaatgatgat gggcatgttc 1260
aacatgctaa gtacagtctt aggagtctca atcctgaatc ttggacaaaa gaagtacacc 1320
aaaacaacat actggtggga cggactccaa tcctctgatg acttcgccct catagtgaat 1380
gcaccaaatc atgagggaat acaagcaggg gtggatagat tctacagaac ctgcaagcta 1440
gtcggaatca atatgagcaa aaagaagtcc tacataaata ggacagggac atttgaattc 1500
acaagctttt tctatcgcta tggatttgta gccaatttta gcatggagct gcccagcttt 1560
ggagtgtctg gaattaatga atcggctgat atgagcattg gggtaacagt gataaagaac 1620
aacatgataa acaatgacct tgggccagca acagcccaac tggctcttca actattcatc 1680
aaagactaca gatatacgta ccggtgccac agaggagaca cacaaattca gacaaggaga 1740
tcattcgagc taaagaagct gtgggggcaa acccgctcaa aggcaggact tttggtttcg 1800
gatggaggac caaacttata caatatccgg aatctccaca ttccagaagt ctgcttgaag 1860
tgggagctaa tggatgaaga ctatcagggg aggctttgta atcccctgaa tccatttgtc 1920
agtcataagg agattgagtc tgtaaacaat gctgtggtaa tgccagctca cggtccagcc 1980
aagagcatgg aatatgatgc tgttactact acacactcct ggatccctaa gaggaaccgc 2040
tccattctca acacaagcca aaggggaatt cttgaagatg aacagatgta tcagaagtgt 2100
tgcaatctat tcgagaaatt cttccctagc agttcgtaca ggagaccagt tggaatttcc 2160
agcatggtgg aggccatggt gtctagggcc cggattgatg cacggattga cttcgagtct 2220
ggacggatta agaaagagga gttcgctgag atcatgaaga tctgttccac cattgaagag 2280
ctcagacggc aaaaatagtg aatttagctt gtccttcatg aaaaaatgcc ttgtttctac 2340
t 2341
<210> 3
<211> 2233
<212> DNA
<213> Influenza virus
<400> 3
agcgaaagca ggtactgatt cgaaatggaa gattttgtgc gacaatgctt caatccgatg 60
attgtcgagc ttgcggaaaa agcaatgaaa gagtatggag aggatctgaa aatcgaaaca 120
aacaaatttg cagcaatatg cactcacttg gaagtatgct tcatgtattc agattttcat 180
ttcatcaatg agcaaggcga gtcaataata gtagagcttg atgatccaaa tgcacttttg 240
aagcacagat ttgaaataat agagggaaga gatcgcacaa tggcctggac agtagtaaac 300
agtatttgca acactacagg agctgagaaa ccgaagtttc tgccagattt gtatgattac 360
aaggagaata gattcatcga gattggagtg acaaggaggg aagtccacat atactatctt 420
gaaaaggcca ataaaattaa atctgagaag acacacatcc acattttctc attcactggg 480
gaagaaatgg ccacaaaggc cgactacact ctcgatgagg aaagcagggc taggatcaaa 540
accagactat tcaccataag acaagaaatg gctagcagag gcctctggga ttcctttcat 600
cagtccgaaa gaggcgaaga aacaattgaa gaaagatttg aaatcacagg gacaatgcgc 660
aggctcgccg accaaagtct cccgccgaac ttctcctgcc ttgagaattt tagagcctat 720
gtggatggat tcgaaccgaa cggctacatt gagggcaagc tttctcaaat gtccaaagaa 780
gtaaatgcta aaattgaacc ttttctgaaa acaacaccaa gaccaattag acttccggat 840
gggcctcctt gttctcagcg gtccaaattc ctgctgatgg atgctttaaa attaagcatt 900
gaggacccaa gtcacgaagg agagggaata ccactatatg atgcgatcaa gtgtatgaga 960
acattctttg gatggaaaga accctatgtt gttaaaccac acgaaaaggg aataaatcca 1020
aattatctgc tgtcatggaa gcaagtactg gcagaactgc aggacattga gaatgaggag 1080
aagattccaa gaaccaaaaa catgaagaaa acgagtcagc taaagtgggc acttggtgag 1140
aacatggcac cagagaaggt agactttgac gactgtagag atgtaagcga tttgaagcaa 1200
tatgatagtg atgaacctga attaaggtca ctttcaagct ggatccagaa tgagttcaac 1260
aaggcatgcg agctgaccga ttcaatctgg atagagctcg atgagattgg agaagatgtg 1320
gctccaattg aacacattgc aagcatgaga aggaattact tcacagcaga ggtgtctcat 1380
tgcagagcca cagaatatat aatgaagggg gtatacatta atactgcctt gcttaatgca 1440
tcctgtgcag caatggacga tttccaacta attcccatga taagcaaatg tagaactaaa 1500
gagggaaggc gaaagaccaa tttatatggt ttcatcataa aaggaagatc tcacttaagg 1560
aatgacaccg acgtggtaaa ctttgtgagc atggagtttt ctctcactga cccaagactt 1620
gagccacaca aatgggagaa gtactgtgtt cttgagatag gagatatgct actaagaagt 1680
gccataggcc aggtgtcaag gcccatgttc ttgtatgtga ggacaaatgg aacatcaaag 1740
attaaaatga aatggggaat ggagatgagg cgttgcctcc ttcagtcact ccaacaaatc 1800
gagagtatga ttgaagccga gtcctctgtc aaggagaaag acatgaccaa agagtttttc 1860
aagaataaat cagaaacatg gcccattgga gagtccccca aaggagtgga agaaggttcc 1920
attgggaagg tctgcaggac tttattagcc aagtcggtat tcaatagcct gtatgcatct 1980
ccacaattag aaggattttc agctgaatca agaaaactgc ttcttgtcgt tcaggctctt 2040
agggacaatc ttgaacctgg gacctttgat cttggggggc tatatgaagc aattgaggag 2100
tgcctgatta atgatccctg ggttttgctt aatgcgtctt ggttcaactc cttcctaaca 2160
catgcattaa gatagttgtg gcaatgctac tatttgctat ccatactgtc caaaaaagta 2220
ccttgtttct act 2233
<210> 4
<211> 1566
<212> DNA
<213> Influenza virus
<400> 4
agcgaaagca gggtagataa tcactcactg agtgacatca aaatcatggc gtcccaaggc 60
accaaacggt cttatgaaca gatggaaact gatggggaac gccagaatgc aaatgaaatc 120
agagcatccg tcgggaagat gattggtgga attggacgat tctacatcca aatgtgcacc 180
gaacttaaac tcagtgatta tgaggggcgg ctgatccaga acagcttaac aatagagaga 240
atggtgctct ctgcttttga cgagaggagg aataaatatc tggaagaaca tcccagcgcg 300
gggaaggatc ctaagaaaac tggaggaccc atatacaaga gagtagatgg aaagtggatg 360
agggaactcg tcctttatga caaagaagaa ataaggcgaa tctggcgcca agctaataat 420
ggtgatgatg caacagctgg tctgactcac atgatgatct ggcattccaa tttgaatgat 480
acaacatacc agaggacaag agctcttgtt cgcaccggaa tggatcccag gatgtgctct 540
ttgatgcagg gttcgactct ccctaggagg tctggagccg caggcgctgc agtcaaagga 600
gttgggacaa tggtgatgga gttgataagg atgatcaaac gtgggatcaa tgatcggaac 660
ttctggagag gtgagaatgg gcggaaaaca aggaatgctt atgagagaat gtgcaacatt 720
ctcaaaggaa aatttcaaac agctgcacaa agagcaatga tggatcaagt gagagaaagc 780
cggaacccag gaaatgctga gatcgaagat ctcatctttc tggcacggtc tgcactcata 840
ttgagagggt cagttgctca caaatcttgt ctgcctgcct gtgtgtatgg acctgccgta 900
gccagtggct acgacttcga aaaagaggga tactctttag tagggataga ccctttcaaa 960
ctgcttcaaa acagccaagt atacagccta atcagaccga atgagaatcc agcacacaag 1020
agtcagctgg tgtggatggc atgcaattct gctgcatttg aagatctaag agtatcaagc 1080
ttcatcagag ggaccaaagt aatcccaagg gggaaacttt ccactagagg agtacaaatt 1140
gcttcaaatg aaaacatgga tactatggga tcaagtactc ttgaactgag aagcaggtac 1200
tgggccataa ggaccagaag tggaggaaac actaatcaac agagggcctc tgcaggtcaa 1260
atcagtgtac aacctacgtt ttctgtgcaa agaaacctcc catttgacaa accaaccatc 1320
atggcagcat tcactgggaa tgcagaggga agaacatcag acatgagggc agaaatcata 1380
aggatgatgg aaggtgcaaa accagaagaa gtgtccttcc aggggcgggg agtcttcgag 1440
ctctcggacg aaaaggcaac gaacccgatc gtgccctctt ttgacatgag taatgaagga 1500
tcttatttct tcggagacaa tgcagaggag tacgacaatt aaggaaaaaa tacccttgtt 1560
tctact 1566
<210> 5
<211> 1027
<212> DNA
<213> Influenza virus
<400> 5
agcgaaagca ggtagatatt gaaagatgag tcttctaacc gaggtcgaaa cgtacgttct 60
ctctatcatc ccgtcaggcc ccctcaaagc cgagatcgca cagagacttg aagatgtctt 120
tgctgggaaa aacaccgatc ttgaggctct catggaatgg ctaaagacaa gaccaatcct 180
gtcacctctg actaagggga ttttgggatt tgtattcacg ctcaccgtgc ccagtgagcg 240
aggactgcag cgtagacgct ttgtccaaaa tgccctcaat gggaatgggg atccaaataa 300
catggacaga gcagttaaac tgtatagaaa gcttaagagg gagataacat tccatggggc 360
caaagaaata gcgctcagtt attctgctgg tgcacttgcc agttgtatgg gcctcatata 420
caacaggatg ggggctgtga ccactgaagt ggtcttaggc ctggtatgtg caacctgtga 480
acagattgct gactcccagc ataggtctca taggcaaatg gtgacaacaa ccaatccact 540
aataagacat gagaacagaa tggttctggc cagcactaca gctaaggcta tggagcaaat 600
ggctggatcg agtgagcaag cagcagaggc catggaggtt gctagtcagg ccaggcaaat 660
ggtgcaggca atgagagtta ttgggactca tcctagctcc agtgctggtc taaaaaatga 720
tcttcttgaa aatttgcagg cctatcagaa acgaatgggg gtgcagatgc aacgattcaa 780
gtgaccctct tgttgttgcc gcgagtatca ttgggatctt gcacttgata ttgtggattc 840
ttgatcatct ttttttcaaa tgcatttatc gcttctttaa acacggtctg aaaagagggc 900
cttctacgga aggagtacca gagtctatga gggaagaata tcgaaaggaa cagcagagtg 960
ctgtggatgc tgacgatagt cattttgtca gcatagagct ggagtaaaaa actaccttgt 1020
ttctact 1027
<210> 6
<211> 890
<212> DNA
<213> Influenza virus
<400> 6
agcgaaagca gggtgacaaa gacataatgg atcctaacac tgtgtcaagc tttcaggtag 60
attgcttcct ttggcatgtc cgcaaacaag ttgcagacca agaactaggt gatgccccat 120
tccttgatcg gcttcgccga gatcagaagt ccctaagggg aagaggcagt actctcggtc 180
tgaacatcga aacagccacc cgtgttggaa agcagatagt ggagaggatt ctgaaggaag 240
aatccgatga ggcacttaaa atgaccatgg cctccgcacc tgcttcgcga tacctaactg 300
acatgactat tgaggaaatg tcaagggact ggttcatgct aatgcccaag cagaaagtgg 360
caggccctct ttgtatcaga atggaccagg caatcatgga taagaacatc atattgaaag 420
cgaatttcag tgtgattttt gaccggctag agaccctaat attactaagg gctttcaccg 480
aagcgggagc aattgttggc gaaatttcac cattgccttc tcttccagga catactaatg 540
aggatgtcaa aaatgcaatt ggggtcctca tcggaggact tgaatggaat gataacacag 600
ttcgagtctc taaaactcta cagagattcg cttggagaag cagtgatgag aatgggagac 660
ctccactcac tccaaaatag aaacggaaaa tggcgagaac aattaggtca aaagttcgaa 720
gaaataagat ggctgattga agaagtgaga cacaaattga agataacaga gaatagtttt 780
gagcaaataa catttatgca agccttacag ctactatttg aagtggaaca agagataaga 840
actttctcgt ttcagcttat ttaatgataa aaaacaccct tgtttctact 890

Claims (5)

1.用反向遗传技术和冷适应株流感病毒骨架,人工构建流感病毒,用作禽流感疫苗生产的种毒。
2.如权利要求1所述的种毒,其特征在于,所述的禽流感病毒PB2、PB1、PA、NP、M、NS基因序列与SEQ ID NO.1、SEQ ID NO.2、SEQ ID NO.3、SEQ ID NO.4、SEQ ID NO.5、SEQ ID NO.6相似性(similarity)高于95%。
3.权利要求2所述的种毒,用于禽流感疫苗或配套的诊断抗原的生产。
4.权利要求2所述的种毒,用于H5亚型禽流感疫苗或配套的诊断试剂的生产。
5.权利要求2所述的种毒,用于H7亚型禽流感疫苗或配套的诊断试剂的生产。
CN201510502806.5A 2015-04-02 2015-08-17 禽流感疫苗和诊断抗原所用种毒的制备方法 Pending CN106190993A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510152425 2015-04-02
CN2015101524259 2015-04-02

Publications (1)

Publication Number Publication Date
CN106190993A true CN106190993A (zh) 2016-12-07

Family

ID=57453094

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510502806.5A Pending CN106190993A (zh) 2015-04-02 2015-08-17 禽流感疫苗和诊断抗原所用种毒的制备方法

Country Status (1)

Country Link
CN (1) CN106190993A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107064499A (zh) * 2017-03-15 2017-08-18 青岛蔚蓝生物制品有限公司 禽流感病毒np蛋白抗原表位多肽及其胶体金试纸盒

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1810961A (zh) * 2006-02-22 2006-08-02 中国人民解放军军事医学科学院微生物流行病研究所 一种重组流感病毒及其制备方法与应用
CN101780275A (zh) * 2009-01-21 2010-07-21 中国农业科学院哈尔滨兽医研究所 H5n1亚型禽流感冷适应弱毒活疫苗的研制及其应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1810961A (zh) * 2006-02-22 2006-08-02 中国人民解放军军事医学科学院微生物流行病研究所 一种重组流感病毒及其制备方法与应用
CN101780275A (zh) * 2009-01-21 2010-07-21 中国农业科学院哈尔滨兽医研究所 H5n1亚型禽流感冷适应弱毒活疫苗的研制及其应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
叶艺: ""A型流感病毒冷适应株的拯救及免疫原性的初步研究"", 《中国优秀硕士学位论文全文数据库(电子期刊)医药卫生科技辑》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107064499A (zh) * 2017-03-15 2017-08-18 青岛蔚蓝生物制品有限公司 禽流感病毒np蛋白抗原表位多肽及其胶体金试纸盒
CN107064499B (zh) * 2017-03-15 2019-06-18 青岛蔚蓝生物制品有限公司 禽流感病毒np蛋白抗原表位多肽及其胶体金试纸盒

Similar Documents

Publication Publication Date Title
US10808229B2 (en) High titer recombinant influenza viruses with enhanced replication in vero cells
CN101472941B (zh) 用于疫苗的高滴度重组流感病毒
US10172934B2 (en) High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs
KR102080914B1 (ko) 인플루엔자 바이러스 돌연변이체들 및 그들의 용도들
US9890363B2 (en) Influenza virus replication for vaccine development
CN102304495A (zh) 高效表达ha蛋白的重组流感病毒及其制备方法和应用
CN108913701B (zh) 一种提高h7n9亚型禽流感疫苗毒株增殖滴度的方法
CN101780275A (zh) H5n1亚型禽流感冷适应弱毒活疫苗的研制及其应用
US20220202927A1 (en) Recombinant influenza viruses with stabilized ha for replication in eggs
US11390649B2 (en) Influenza virus replication for vaccine development
CN108018300A (zh) 区分免疫和感染动物h7亚型禽流感疫苗株及其制备方法和应用
KR101835989B1 (ko) 인플루엔자 바이러스의 다중 아형 h3 및 h7 에 대한 다중 교차 면역반응을 형성하는 신규한 재조합 인플루엔자 바이러스 및 이를 포함하는 백신
CN106190993A (zh) 禽流感疫苗和诊断抗原所用种毒的制备方法
CN108048476B (zh) 一种制备区分免疫和感染动物h9亚型禽流感疫苗株的方法及应用
CN101947317B (zh) 一种h5n1禽流感病毒样颗粒疫苗的规模化制备方法
CN104109655B (zh) H7亚型禽流感疫苗和诊断试剂所需种毒的制备方法
RU2507256C2 (ru) Штамм вируса гриппа а/17/mallard/нидерланды/00/95(h7n3) для производства живой и производства инактивированной гриппозных вакцин
CN108103084A (zh) 区分免疫和感染动物h5亚型禽流感疫苗株及其制备方法和应用
Liu et al. Efficacy of a high-yield attenuated vaccine strain wholly derived from avian influenza viruses by use of reverse genetics
RU2606019C1 (ru) Вакцинный штамм вируса гриппа А/17/ГОНКОНГ/2014/8296 (H3N2) для производства живой гриппозной интраназальной вакцины для взрослых и для детей
CN109880835A (zh) 重组h9n2禽流感病毒株、其制备方法、禽流感疫苗及其应用
US11214799B2 (en) HA-specific influenza virus attenuated vaccine comprising mutations in segment 7, and uses therefor
CN111269895B (zh) 甲型流感病毒减毒株及其作为骨架病毒和疫苗的应用
KR101857863B1 (ko) 신규한 조류 인플루엔자 h5n9 재조합 바이러스 및 이를 포함하는 백신 조성물
WO2024038382A1 (en) Modified influenza viruses

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20161207

WD01 Invention patent application deemed withdrawn after publication